Sona Asset Management »

BioMarin Pharmaceutical shares owned by Sona Asset Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Sona Asset Management from 13F filings

Historical chart of Sona Asset Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Sona Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Sona Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.2B 13k 89000.00
2022-12-31 $792k 7.7k 103.49
2022-09-30 $648k 7.7k 84.71
2022-06-30 $679k 8.2k 83.06

More positions owned by Sona Asset Management

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Apollo Global Mgmt Ser A Mand Cnv (APO.PA)
Insight Enterprises Note 0.750% 2/1
Ncl Corp Note 2.500% 2/1
Rapid7 Note 0.250% 3/1
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Greenfire Res Com Shs (GFR)
Neurocrine Biosciences Note 2.250% 5/1
Dropbox Note3/0
Biomarin Pharmaceutical Note 0.599% 8/0
Dropbox Note3/0
Sea Note 2.375%12/0
Mongodb Note 0.250% 1/1
Sea Note 0.250% 9/1
American Airlines Group Note 6.500% 7/0

View all positions for Sona Asset Management

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings
Parnassus Investments

View all funds holding BioMarin Pharmaceutical